CF
53
2
KEY
46
-2
SLB
56
-3
EQT
57
-3
TXT
62
2
GPC
40
2
XOM
51
3
ZTS
49
2
PSX
47
3
FLR
48
3
NWSA
71
-2
C
62
-3
SE
60
-5
FLS
76
-2
KHC
17
4
DTE
38
-4
LOW
58
2
AMAT
43
-5
NWS
79
-4
GILD
56
-4
CF
53
2
KEY
46
-2
SLB
56
-3
EQT
57
-3
TXT
62
2
GPC
40
2
XOM
51
3
ZTS
49
2
PSX
47
3
FLR
48
3
NWSA
71
-2
C
62
-3
SE
60
-5
FLS
76
-2
KHC
17
4
DTE
38
-4
LOW
58
2
AMAT
43
-5
NWS
79
-4
GILD
56
-4
Financhill
Back

BetaPro S&P/TSX Cap Fncl -2xDlyBear ETF Vs. Dyne Therapeutics Industry Stock Comparison

Sell
45

HFD.TO
BetaPro S&P/TSX Cap Fncl -2xDlyBear ETF

Last Price:
6.28
Seasonality Move:
0.96%
Buy
66

DYN
Dyne Therapeutics

Last Price:
30.40
Seasonality Move:
38.02%
Sell
45
BetaPro S&P/TSX Cap Fncl -2xDlyBear ETF (HFD.TO) is a Sell

Is BetaPro S&P/TSX Cap Fncl -2xDlyBear ETF a Buy, Sell or Hold?

  • The current BetaPro S&P/TSX Cap Fncl -2xDlyBear ETF [HFD.TO] share price is $6.33. The Score for HFD.TO is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • HFD.TO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
66
Dyne Therapeutics (DYN) is a Buy

Is Dyne Therapeutics a Buy, Sell or Hold?

  • The current Dyne Therapeutics [DYN] share price is $34.14. The Score for DYN is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • DYN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

HFD.TO Stock Price Chart

What is BetaPro S&P/TSX Cap Fncl -2xDlyBear ETF's stock price today?

  • The BetaPro S&P/TSX Cap Fncl -2xDlyBear ETF share price today is $6.33
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HFD.TO is experiencing slight buying pressure.

DYN Stock Price Chart

What is Dyne Therapeutics's stock price today?

  • The Dyne Therapeutics share price today is $34.14
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DYN is experiencing buying pressure, which is a positive indicator for future bullish movement.

HFD.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.19 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: 4940 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.49 - 6.89) Sell
Bollinger Bands (100): (6.87 - 8.79) Sell

DYN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.99 Sell
Relative Strength Index (14 RSI): 60.64 Buy
Chaikin Money Flow: 1192325 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.99 - 33.51) Buy
Bollinger Bands (100): (31.49 - 42.59) Sell

HFD.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.47 Sell
20-day SMA: 6.64 Sell
50-day SMA: 6.98 Sell
200-day SMA: 8.61 Sell
8-day EMA: 6.45 Sell
20-day EMA: 6.63 Sell
50-day EMA: 7.04 Sell
200-day EMA: 8.44 Sell

DYN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.58 Buy
20-day SMA: 30.81 Buy
50-day SMA: 32.62 Buy
200-day SMA: 32.06 Buy
8-day EMA: 30.24 Buy
20-day EMA: 30.74 Buy
50-day EMA: 32.95 Buy
200-day EMA: 30.83 Buy

BetaPro S&P/TSX Cap Fncl -2xDlyBear ETF Earnings Growth & HFD.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Dyne Therapeutics Earnings Growth & DYN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.54 per share, and an increase next year of $0.08 per share.

BetaPro S&P/TSX Cap Fncl -2xDlyBear ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Dyne Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):